BO
GILD icon

Bach Option’s Gilead Sciences GILD Stock Holding History

Bach Option’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,126
Closed -$208K – 91
2017
Q1 		$212K Sell
3,126
-3,776
-55% -$266K 0.16% 100
2016
Q4 		$494K Buy
+6,902
New +$513K 0.22% 129
2016
Q3 		– Sell
-4,090
Closed -$332K – 182
2016
Q2 		$341K Buy
4,090
+1,773
+77% +$157K 0.14% 141
2016
Q1 		$213K Buy
+2,317
New +$209K 0.13% 116

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bach Option's GILD Position: Q2 2017 in Review

Bach Option sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 3,126 shares — an estimated $208K sold.

Bach Option first reported a position in GILD in Q1 2016 and held it in 4 quarters. The position peaked at $494K in Q4 2016. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Bach Option reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Bach Option sold 3,126 Gilead Sciences shares in Q2 2017, an estimated $208K.
  • Bach Option first reported a position in Gilead Sciences in Q1 2016 and held it in 4 quarters.
  • Bach Option's Gilead Sciences position peaked at $494K in Q4 2016.
  • 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Bach Option's 13F filing for Q2 2017, filed 13 Jul 2017.